Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2020.06.18
公司债券2020年跟踪评级报告
2020.06.17
《公司章程》（H股发行后适用）修订对照表
2020.06.17
第四届董事会第三十五次会议决议公告
2020.06.16
关于刊发H股发行聆讯后资料集的公告
2020.06.13
关于香港联合交易所有限公司审议公司发行境外上市外资股的公告
2020.06.12
关于第二期和第三期员工持股计划的提示性公告
2020.05.22
2019年年度股东大会的法律意见书
2020.05.22
2019年年度股东大会决议公告
第一页
上一页
59
60
61
62
63
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
